Instalab ResearchOver the last decade, wearable devices have evolved from simple step counters into multi-sensor health monitors capable of tracking heart rate, oxygen saturation, body movement, and even cardiac signals through photoplethysmography (PPG) and inertial measurement units (IMUs). The Apple Watch, with its large user base and powerful sensor suite, is uniquely positioned for large-scale sleep health monitoring.
Multiple studies have explored the feasibility of using consumer-grade wearables for sleep tracking, with the Apple Watch showing high accuracy in detecting sleep and wake states compared to validated actigraphy devices. The question is whether this performance extends to identifying breathing-related disorders like sleep apnea.
A recent pilot study used only the Apple Watch’s IMU sensors to detect sleep apnea. By extracting seismocardiographic and respiratory signals from wrist movements and subtle body vibrations, researchers analyzed over 52,000 30-second epochs from adults undergoing PSG. Nearly a quarter represented apnea or hypopnea events.
Machine learning algorithms, particularly a Random Forest classifier, achieved strong predictive performance:
These findings suggest the Apple Watch could serve as a high-accessibility screening tool for sleep apnea without additional hardware, potentially transforming early diagnosis rates.
In addition to motion-based detection, other studies have evaluated the Apple Watch’s ability to monitor cardiorespiratory signals relevant to apnea diagnosis.
Patients with obstructive sleep apnea often have cardiovascular comorbidities such as atrial fibrillation. Research has shown the Apple Watch to have strong agreement with clinical telemetry in heart rate measurement for these patients, suggesting it can provide reliable heart rate data that may be incorporated into apnea screening models.
The Apple Watch also uses PPG-based sensors to estimate oxygen saturation, another key metric in apnea detection. Studies comparing it to PSG found moderate diagnostic accuracy for detecting mild OSA, although accuracy declined with increasing apnea severity. This indicates oxygen data should be combined with other measurements for reliable detection.
The Apple Watch is not the only smartwatch under investigation for apnea detection, but it compares favorably with others. Research on smartwatch-based OSA detection against PSG in large participant groups has found high sensitivity and specificity, particularly in severe apnea cases.
Other PPG-based wearable devices have demonstrated sensitivity above 80% and specificity close to 90% for moderate-to-severe apnea detection when analyzing heart rate variability patterns. These findings suggest that as detection algorithms improve, consumer smartwatches will become increasingly viable tools for apnea screening.
With more than 30 million Apple Watches in circulation, even modest screening accuracy could dramatically expand early detection, especially in communities with limited access to sleep clinics. In the future, nightly watch data could quietly flag potential apnea events, prompting users to seek a formal sleep study. This could shorten diagnosis timelines from years to weeks.
Research is progressing toward fully automated algorithms that combine motion, heart rate, and oxygen data for robust apnea screening. As these algorithms integrate into consumer devices, the gap between medical-grade and consumer-grade monitoring will continue to narrow.
If you suspect you may have sleep apnea, you can order a validated at-home sleep test kit like the WatchPAT One. This FDA-cleared device features a wrist sensor, pulse oximeter, and chest sensor, using three points of contact: the wrist, finger, and neck. It measures central and obstructive sleep apnea events, true sleep time, snoring, breathing rates, oxygen levels, heart rate, body position, and sleep stages.
